Chengdu Olymvax Biopharmaceuticals Inc. 688319.SS Stock
Chengdu Olymvax Biopharmaceuticals Inc. Price Chart
Chengdu Olymvax Biopharmaceuticals Inc. 688319.SS Financial and Trading Overview
Contents
| Chengdu Olymvax Biopharmaceuticals Inc. stock price | 7.91 CNY |
| Previous Close | 21.29 CNY |
| Open | 21.4 CNY |
| Bid | 21.07 CNY x N/A |
| Ask | 21.09 CNY x N/A |
| Day's Range | 21.02 - 21.43 CNY |
| 52 Week Range | 13.09 - 25 CNY |
| Volume | 1.64M CNY |
| Avg. Volume | 2.83M CNY |
| Market Cap | 8.54B CNY |
| Beta (5Y Monthly) | 0.808802 |
| PE Ratio (TTM) | 234.1111 |
| EPS (TTM) | 0.04 CNY |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 24.04 CNY |
688319.SS Valuation Measures
| Enterprise Value | 8.79B CNY |
| Trailing P/E | 234.1111 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 15.225891 |
| Price/Book (mrq) | 9.660706 |
| Enterprise Value/Revenue | 15.665 |
| Enterprise Value/EBITDA | 170.971 |
Trading Information
Chengdu Olymvax Biopharmaceuticals Inc. Stock Price History
| Beta (5Y Monthly) | 0.808802 |
| 52-Week Change | 10.36% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 25 CNY |
| 52 Week Low | 13.09 CNY |
| 50-Day Moving Average | 21.35 CNY |
| 200-Day Moving Average | 18.13 CNY |
688319.SS Share Statistics
| Avg. Volume (3 month) | 2.83M CNY |
| Avg. Daily Volume (10-Days) | 3.74M CNY |
| Shares Outstanding | 405.26M |
| Float | 194.77M |
| Short Ratio | N/A |
| % Held by Insiders | 57.69% |
| % Held by Institutions | 0.068% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 6.63% |
| Operating Margin (ttm) | 5.12% |
| Gross Margin | 91.57% |
| EBITDA Margin | 9.16% |
Management Effectiveness
| Return on Assets (ttm) | 1.37% |
| Return on Equity (ttm) | 4.12% |
Income Statement
| Revenue (ttm) | 560.82M CNY |
| Revenue Per Share (ttm) | 1.38 CNY |
| Quarterly Revenue Growth (yoy) | 24.89% |
| Gross Profit (ttm) | 547.48M CNY |
| EBITDA | 51.38M CNY |
| Net Income Avi to Common (ttm) | 37.24M CNY |
| Diluted EPS (ttm) | 0.09 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 297.89M CNY |
| Total Cash Per Share (mrq) | 0.74 CNY |
| Total Debt (mrq) | 118.04M CNY |
| Total Debt/Equity (mrq) | 13.22 CNY |
| Current Ratio (mrq) | 2.073 |
| Book Value Per Share (mrq) | 2.181 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -14527877 CNY |
| Levered Free Cash Flow (ttm) | -166699232 CNY |
Profile of Chengdu Olymvax Biopharmaceuticals Inc.
| Country | China |
| State | N/A |
| City | Chengdu |
| Address | No. 99 Tianxin Road |
| ZIP | 611731 |
| Phone | 86 28 6936 1111 |
| Website | https://www.olymvax.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 440 |
Chengdu Olymvax Biopharmaceuticals Inc. engages in the research and development, production, and sale of human vaccines. The company offers adsorbed tetanus vaccine; Hib conjugate vaccine; Group A streptococcus vaccine; and AC conjugate vaccine. It also provides vaccines for haemophilus influenzae type b; group A and C meningococcal; and Staphylococcus aureus, which is in Phase 2 clinical trial. In addition, the company engages in promotion and application service business. Chengdu Olymvax Biopharmaceuticals Inc. was founded in 2009 and is based in Chengdu, China.
Q&A For Chengdu Olymvax Biopharmaceuticals Inc. Stock
What is a current 688319.SS stock price?
Chengdu Olymvax Biopharmaceuticals Inc. 688319.SS stock price today per share is 7.91 CNY.
How to purchase Chengdu Olymvax Biopharmaceuticals Inc. stock?
You can buy 688319.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Chengdu Olymvax Biopharmaceuticals Inc.?
The stock symbol or ticker of Chengdu Olymvax Biopharmaceuticals Inc. is 688319.SS.
Which industry does the Chengdu Olymvax Biopharmaceuticals Inc. company belong to?
The Chengdu Olymvax Biopharmaceuticals Inc. industry is Biotechnology.
How many shares does Chengdu Olymvax Biopharmaceuticals Inc. have in circulation?
The max supply of Chengdu Olymvax Biopharmaceuticals Inc. shares is 406.16M.
What is Chengdu Olymvax Biopharmaceuticals Inc. Price to Earnings Ratio (PE Ratio)?
Chengdu Olymvax Biopharmaceuticals Inc. PE Ratio is 197.75000000 now.
What was Chengdu Olymvax Biopharmaceuticals Inc. earnings per share over the trailing 12 months (TTM)?
Chengdu Olymvax Biopharmaceuticals Inc. EPS is 0.04 CNY over the trailing 12 months.
Which sector does the Chengdu Olymvax Biopharmaceuticals Inc. company belong to?
The Chengdu Olymvax Biopharmaceuticals Inc. sector is Healthcare.